Merck
MRK
#45
Rank
$297.40 B
Marketcap
$120.29
Share price
1.85%
Change (1 day)
35.36%
Change (1 year)

P/S ratio for Merck (MRK)

P/S ratio as of April 2026 (TTM): 4.57

According to Merck's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.65. At the end of 2025 the company had a P/S ratio of 4.09.

P/S ratio history for Merck from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20254.094.06%
20243.93-14.47%
20234.60-3.15%
20224.7519.38%
20213.97-13.85%
20204.61-6.41%
20194.935.25%
20184.6822.58%
20173.82-6.29%
20164.089.63%
20153.72-2.54%
20143.8214.68%
20133.3326.93%
20122.629.62%
20112.39-0.99%
20102.42-41.67%
20094.1453.66%
20082.69-48.35%
20075.2224.95%
20064.1832.42%
20053.151.89%
20043.09-32.21%
20034.5658.76%
20022.881.15%
20012.84

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.25 36.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.21 13.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.55-44.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
4.02-12.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
12.6 176.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
5.16 12.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2.18-52.43%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
2.57-43.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2.54-44.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
2.03-55.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel